| |
| |
|
| Insider
Information: |
Butler John P. |
| Relationship: |
|
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
2,064,580 |
|
|
Indirect Shares
|
319,856 |
|
|
| Direct
Value |
$2,330,821 |
|
|
|
Indirect Value
|
$364,636 |
|
|
| Total
Shares |
2,384,436 |
|
|
| Total
Value |
$2,695,457 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
11
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
8
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -26.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Akebia Therapeutics, Inc. |
AKBA |
|
2024-02-29 |
2,044,580 |
2024-02-29 |
319,856 |
Premium* |
|
|
Relypsa Inc |
RLYP |
Director |
2016-09-01 |
0 |
2014-06-19 |
0 |
Premium* |
|
|
Keryx Biopharmaceuticals Inc |
KERX |
Director |
2017-06-09 |
20,000 |
|
0 |
Premium* |
|
|
Zynerba Pharmaceuticals, Inc. |
ZYNE |
|
2023-10-10 |
0 |
2018-08-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
48 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2015-12-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
- |
|
| RLYP |
Relypsa Inc |
Director |
– • – |
2014-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
2,712 |
2,712 |
0 |
- |
|
| RLYP |
Relypsa Inc |
Director |
– • – |
2015-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
4,962 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
CEO and President |
• • – |
2016-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
125,500 |
351,173 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2016-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| RLYP |
Relypsa Inc |
Director |
– • – |
2016-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
5,099 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2017-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
20,000 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
CEO and President |
• • – |
2018-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
88,900 |
408,814 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
CEO and President |
• • – |
2018-12-12 |
4/A |
A |
$0.00 |
$0 |
D/D |
1,248 |
375,865 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
CEO and President |
• • – |
2019-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
239,500 |
614,382 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
CEO and President |
• • – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
237,400 |
1,026,632 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
CEO and President |
• • – |
2021-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
237,400 |
1,166,732 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
CEO and President |
• • – |
2021-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
39,520 |
1,156,262 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Director |
– • – |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
10,000 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
CEO and President |
• • – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
293,125 |
1,457,220 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Director |
– • – |
2022-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
23,109 |
33,109 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
CEO and President |
• • – |
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
293,125 |
1,699,372 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Director |
– • – |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
47,824 |
80,880 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
|
• • – |
2023-10-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(80,765) |
0 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
CEO and President |
• • – |
2024-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
603,500 |
2,175,372 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Director |
– • – |
2023-06-14 |
4 |
S |
$0.35 |
$40 |
D/D |
(115) |
80,765 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
CEO and President |
• • – |
2014-11-11 |
4 |
OE |
$0.47 |
$14,335 |
D/D |
30,500 |
44,350 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
CEO and President |
• • – |
2015-03-09 |
4 |
OE |
$0.47 |
$47,000 |
D/D |
100,000 |
148,350 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
CEO and President |
• • – |
2015-05-26 |
4 |
OE |
$0.47 |
$23,500 |
D/D |
50,000 |
198,350 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
CEO and President |
• • – |
2016-01-15 |
4 |
OE |
$0.47 |
$11,750 |
D/D |
25,000 |
225,673 |
0 |
- |
|
48 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
